Drug Development Leadership Trends 
Digital Health Global
FEBRUARY 19, 2024
Centered on digital biomarker and safety monitoring algorithm development, with a specific emphasis on cytokine release syndrome (CRS) detection, the oncology programs harness cutting-edge data science and technology to elevate remote data collection, patient monitoring, and safety protocols. Full press release here
Healthcare IT Today
JANUARY 3, 2025
AI capabilities will become a critical differentiator, with companies that successfully implement AI solutions gaining significant advantages in drug discovery and development speed, cost reduction, and market intelligence. It’s not just a trend, but a reality we fully expect will accelerate in the coming year.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Digital Health Global
NOVEMBER 12, 2024
These developments underscore the ongoing challenges and transformations in both the energy and biotechnology sectors, reflecting broader trends towards sustainability and financial stability. 23andMe tried to monetize its extensive genetic database by collaborating with pharmaceutical companies for drug research.
Healthcare IT Today
JANUARY 4, 2025
Amid a history of high-profile breaches, more organizations are taking a proactive approach to cybersecurity and having discussions at a leadership level. On the pharma front, expect an emphasis on AI for inventory management and targeted drug development , plus a shake-up in the market for weight-loss drugs.
Lloyd Price
NOVEMBER 16, 2024
MarketScan: Offering comprehensive data on healthcare costs and utilisation trends. Clinical Development: Supporting clinical research and development through real-world evidence and advanced analytics. Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions.
Lloyd Price
OCTOBER 14, 2024
Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Regulatory Landscape: Changes in healthcare regulations and policies.
Lloyd Price
DECEMBER 2, 2024
Key Trends Shaping Valuations: Consolidation and M&A: Larger companies may acquire smaller, innovative startups to expand their product portfolios and accelerate growth. By closely monitoring these trends and adapting to the evolving landscape, HealthTech companies can position themselves for long-term success and significant valuations.
Expert insights. Personalized for you.
166 
Let's personalize your content